QQ客服 官方微博 反馈留言

	Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study
	Xing, Puyuan; Ma, Di; Wang, Qiang; Hao, Xuezhi; Wang, Mengzhao; Wang, Yan; Shan, Li; Xin, Tao; Liang, Li; Liang, Hongge
	2019
卷号	31期号:3页码:481-+
关键词	Crizotinib anaplastic lymphoma kinase non-small-cell lung cancer real-world study
ISSN号	1000-9604
DOI	10.21147/j.issn.1000-9604.2019.03.10
URL标识	查看原文
收录类别	SCIE ; PUBMED ; CSCD
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6339043
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Xing, Puyuan,Ma, Di,Wang, Qiang,et al. Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study[J],2019,31(3):481-+.
APA	Xing, Puyuan.,Ma, Di.,Wang, Qiang.,Hao, Xuezhi.,Wang, Mengzhao.,...&Li, Junling.(2019).Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study.,31(3),481-+.
MLA	Xing, Puyuan,et al."Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study".31.3(2019):481-+.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。